NCT00375050View on ClinicalTrials.gov

Treatment of Refractory Schizophrenia With Riluzole

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

August 29, 2006

Study Completion Date

August 29, 2006

Conditions
SchizophreniaSchizoaffective
Interventions
DRUG

Riluzole

DRUG

Placebo

placebo

Trial Locations (1)

06519

Yale Department of Psychiatry, New Haven

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Yale University

OTHER

NCT00375050 - Treatment of Refractory Schizophrenia With Riluzole | Biotech Hunter | Biotech Hunter